Osteologix, Inc. 4
4 · Osteologix, Inc. · Filed Jun 11, 2010
Insider Transaction Report
Form 4
Osteologix, Inc.OLGX OB
Nordic Biotech General Partner ApS
10% Owner
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2010-06-11$0.50/sh+1,494,532$749,956→ 6,517,264 total(indirect: By Nordic Biotech Opportunity Fund K/S)
Holdings
- 15,133,061(indirect: By Nordic Biotech K/S)
Common Stock, par value $0.0001 per share
Footnotes (2)
- [F1]Nordic Biotech General Partner ApS is the managing partner of Nordic Biotech Opportunity Fund K/S. Nordic Biotech General Partner ApS hereby disclaims any beneficial ownership of the securities held directly by Nordic Biotech Opportunity Fund K/S for purposes of Section 16 of the Act, except to the extent of its indirect pecuniary interest therein.
- [F2]Nordic Biotech General Partner ApS is the managing partner of Nordic Biotech K/S. Nordic Biotech General Partner ApS hereby disclaims any beneficial ownership of the securities held directly by Nordic Biotech K/S for purposes of Section 16 of the Act, except to the extent of its indirect pecuniary interest therein.